跳至主要内容
临床试验/NCT02576223
NCT02576223已完成不适用

Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery - a Randomized, Blinded, Placebo Controlled Study

Kai Henrik Wiborg Lange2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
2
主要终点
Visual analogue scale (VAS) score at rest at T½

研究概览

简要总结

The purpose of this randomized study is to examine the effect of a selective suprascapular nerve block on post operative pain after arthroscopic shoulder surgery. Half of the subjects will receive a active nerve block with Ropivacain. Half of the subjects will receive a placebo nerve block with saline.

详细描述

Postoperative pain management after arthroscopic shoulder surgery traditionally includes opioids and/or an interscalene brachial plexus block(IBPB). Opioid consumption often leads to unpleasant side effects including nausea, vomitting and sedation. IBPB offers very efficient pain relief but includes the discomfort of a paralyzed arm. Furthermore this approach often also leads to unilateral paresis of the phrenic nerve causing reduced respiratory capacity. The latter offering discomfort and a potential risk in patients with lung diseases or heavy overweight.

The suprascapular nerve is the most important nerve to the shoulder and a selective block of this nerve could offer a good pain relief without the mentioned side effects.

In this randomized study the investigators wish to examine the pain relieving effect of a selective block of the suprascapular nerve after arthroscopic shoulder surgery.

40 patients are randomized to a block of this nerve with either active drug (Ropivacaine) or placebo (Saline). All patients will get a PCA (Patient Controlled Analgesia) pump for administration of i.v. morphine in doses based on age and weight.

Patient are being monitored for 6 hours. The primary outcome is reduction in VAS at rest from baseline to 30 minutes after nerve block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients planned for arthroscopic shoulder surgery.
  • ASA class ≤ 3.

排除标准

  • Patients with VAS never ≥5 mm during the first hour after arrivel to the post anesthesia care unit.
  • Patients unable to cooperate.
  • Patients unable to understand or speak danish.
  • Allergy towards the used drugs.
  • Abuse of alcohol- and/or medicine - investigators assessment.
  • Usage of opioids on a daily basis (not including Tramadole).
  • Pregnancy (It is obligatory for all fertile women in the study to take a hcg urine test).
  • Operations involving the clavicle.
  • Operations converted to open surgery.

研究组 & 干预措施

Ropivacaine hydrochloride

Active Comparator

Ropivacain 7.5mg/ml, 5 ml injected perineural at the suprascapular nerve.

干预措施: Ropivacaine hydrochloride (Drug)

Ropivacaine hydrochloride

Active Comparator

Ropivacain 7.5mg/ml, 5 ml injected perineural at the suprascapular nerve.

干预措施: PCA-pump (Drug)

Isotonic Saline

Placebo Comparator

0.9% Saline solution, 5 ml injected perineural at the suprascapular nerve.

干预措施: Isotonic Saline (Drug)

Isotonic Saline

Placebo Comparator

0.9% Saline solution, 5 ml injected perineural at the suprascapular nerve.

干预措施: PCA-pump (Drug)

结局指标

主要结局

Visual analogue scale (VAS) score at rest at T½

时间窗: Baseline to 30 minutes

Change in VAS score at rest from baseline to 30 minutes after nerve block (T½).

次要结局

  • VAS score during maximum active shoulder abduction from T½ to T6(½, 1, 2, 3, 4, 5, 6 hours)
  • Morphine consumption.(6 hours)
  • VAS score at rest from T½ to T6(½, 1, 2, 3, 4, 5, 6 hours)
  • Muscle strength at T½(Baseline to 30 minutes)
  • Electromyography at T½(Baseline to 30 minutes)

研究者

发起方
Kai Henrik Wiborg Lange
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kai Henrik Wiborg Lange

Head of Research

Hillerod Hospital, Denmark

研究点 (2)

Loading locations...

相似试验